Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.
- 1 October 1982
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 79 (19), 6038-6041
- https://doi.org/10.1073/pnas.79.19.6038
Abstract
Glanzmann thrombasthenia is an inherited bleeding disorder characterized by the failure of platelets to aggregate in response to almost all stimuli. Thrombasthenic platelets aggregated with bovine and porcine von Willebrand factor (vWF) and showed normal ristocetin-induced binding and aggregation in the presence of human vWF. The specific binding of vWF to the thrombin-stimulated platelets was < 20% of normal in 3 patients with Glanzmann thrombasthenia. Analysis of binding isotherms was based on the assumption of 1 class of binding sites for vWF on the platelet membrane. Double-reciprocal plots were used to calculate maximal binding at saturation and apparent Kd. In 9 normals, 2.82 .+-. 0.64 .mu.g (.+-. SD) of vWF bound to 108 platelets at saturation, with Kd (.+-. SD) = 3.65 .+-. 1.23 .mu.g/ml. In 2 patients with thrombasthenia, binding was markedly decreased and did not approach saturation. In the 3 patients, binding at saturation corresponded to 0.21 .mu.g/108 platelets, with Kd = 3.93 .mu.g/ml. Mechanisms underlying the vWF-platelet interaction are incompletely reflected in ristocetin-dependent assay systems. The platelet defect in Glanzmann thrombasthenia is apparently not limited to decreased binding of fibrinogen but involves several glycoproteins that are known to interact with platelets.This publication has 27 references indexed in Scilit:
- Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.Journal of Clinical Investigation, 1982
- Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.Journal of Clinical Investigation, 1981
- Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis.Journal of Clinical Investigation, 1981
- Exposure of platelet fibrinogen receptors by ADP and epinephrine.Journal of Clinical Investigation, 1979
- Deletion of the Platelet-Specific Alloantigen PlA1 from Platelets in Glanzmann's ThrombastheniaJournal of Clinical Investigation, 1978
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Platelet Membrane Defects in Glanzmann's ThrombastheniaJournal of Clinical Investigation, 1977
- Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.Journal of Clinical Investigation, 1976
- Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.Journal of Clinical Investigation, 1975
- An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's ThrombastheniaBritish Journal of Haematology, 1974